Androgens, aging, and prostate health
Мусаева Лола Жураевна, Акбарова Дилфуза Суратовна, Содикова Самирахон Абдувалиевна
- 24 Jun 2022
Vol. 23, Iss: 6, pp 1221-1231
TL;DR: In this article , a review summarizes existing data on the associations between endogenous hormone concentrations and prostate growth and concludes that circulating concentrations of androgens do not appear to be associated with the risks of development of BPH or initiation or progression of PC.
read more
Abstract: Abstract Due to late onset hypogonadism (LOH), there is an increased usage of testosterone replacement therapy (TRT) in the aging male population. Since prostate is a target organ for androgens and anti-androgenic strategies are used to treat and palliate benign prostate hyperplasia (BPH) and prostate cancer (PC), the prevalence of both increases with age, the possible influence of TRT on prostate health becomes highly relevant. The present review summarizes existing data on the associations between endogenous hormone concentrations and prostate growth and concludes that circulating concentrations of androgens do not appear to be associated with the risks of development of BPH or initiation or progression of PC. The explanation for these findings relates to an apparent insensitivity of prostatic tissue to changes of testosterone concentrations within the physiological range.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
TL;DR: In this paper , the authors focus on elucidating how various endogenous and exogenous stresses (such as genomic instability, telomere dysfunction, epigenetic alterations, loss of proteostasis, compromise of autophagy, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, deregulated nutrient sensing) participate in the regulation of aging.
Capsaicin reduces blood glucose and prevents prostate growth by regulating androgen, RAGE/IGF-1/Akt, TGF-β/Smad signalling pathway and reversing epithelial-mesenchymal transition in streptozotocin-induced diabetic mice
Hui Sun,Z Wang,Bing Tu,ZiChen Shao,YiDan Li,Dongyi Han,Yinjie Jiang,Chengqi Zhang,WeiChang Zhang,Ying Wang,Xiaoming Wu,Chi-Ming Liu +11 more
Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia
Song Jin,Peng Xiang,Meng Fu,Gang Zhang,Jianxing Li +4 more
Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia
Tao Zhang,Changlin Mao,Yao Chang,Jia Lyu,Delong Zhao,Sentai Ding +5 more
TL;DR: In hypoxia, activation of the HIF-1α/VEGF pathway plays a crucial role in regulating cell proliferation in a BPH stromal cell line, and regulation by miR-17-5p may be the potential mechanism for the activation of this pathway.
Preoperative high serum total testosterone levels predict preserved postoperative sexual function in patients after nerve‐sparing robot‐assisted radical prostatectomy
Kohei Saito,Yuki Kohada,Keisuke Hieda,Hiroyuki Shikuma,Takashi Hatayama,Ryo Tasaka,Shunsuke Miyamoto,Kohei Kobatake,Yohei Sekino,Hiroyuki Kitajima,Keisuke Goto,Kenichiro Ikeda,Akihiro Goriki,Nobuyuki Hinata +13 more
TL;DR: Preoperative high serum total testosterone levels predict preserved postoperative sexual function in patients after nerve-sparing robot-assisted radical prostatectomy.
References
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
TL;DR: A better understanding of the pathophysiology of BPH/BPE is a prerequisite for the development of novel, more effective medical treatment options.
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
Victor Laurent,Victor Laurent,Adrien Guerard,Adrien Guerard,Catherine Mazerolles,Sophie Le Gonidec,Sophie Le Gonidec,Aurélie Toulet,Aurélie Toulet,Laurence Nieto,Laurence Nieto,Falek Zaidi,Bilal Majed,David Garandeau,David Garandeau,Youri Socrier,Muriel Golzio,Muriel Golzio,Thomas Cadoudal,Thomas Cadoudal,Karima Chaoui,Karima Chaoui,Cédric Dray,Cédric Dray,Bernard Monsarrat,Bernard Monsarrat,Odile Schiltz,Odile Schiltz,Yuan Yuan Wang,Yuan Yuan Wang,Bettina Couderc,Philippe Valet,Philippe Valet,Bernard Malavaud,Catherine Muller,Catherine Muller +35 more
TL;DR: It is shown that adipocytes from PPAT support the directed migration of prostate cancer cells and that this event is strongly promoted by obesity, highlighting the potential benefit of CCR3 antagonists in the treatment of prostate cancers.
The relationship between circulating testosterone and inflammatory cytokines in men.
Nur-Vaizura Mohamad,Sok Kuan Wong,Wan Nuraini Wan Hasan,James Jam Jolly,Mohd Fozi Nur-Farhana,Soelaiman Ima-Nirwana,Kok-Yong Chin +6 more
TL;DR: In conclusion, testosterone may possess anti-inflammatory properties but its magnitude is debatable and more evidence is needed to validate the use of testosterone as a marker and in the management of chronic inflammatory diseases.
246
Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.
Joel M. Kaufman,R. James Graydon +1 more
TL;DR: Based on the clinical experience with this small group of men, and indirect evidence of the safety of this approach from epidemiological and clinical data, further cautious use of testosterone in a carefully selected population seems warranted.
237
Roles for the Stem Cell–Associated Intermediate Filament Nestin in Prostate Cancer Migration and Metastasis
Wolfram Kleeberger,G. Steven Bova,Matthew E. Nielsen,Mehsati Herawi,Ai Ying Chuang,Jonathan I. Epstein,David M. Berman +6 more
TL;DR: A function for Nestin in cell motility is specified and a novel pathway for prostate cancer metastasis is identified, which may be selected by the extraprostatic environment or originate within the prostate after androgen deprivation.
217